Deciphera Pharmaceuticals, Inc. Announces Publication of INTRIGUE Phase 3 Clinical Study Results in Journal of Clinical Oncology – Efficacy Observed with QINLOCK® was Comparable to Sunitinib with a More Favorable Safety and Tolerability Profile in GIST Patients...
Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million High-profile investors led by T. Rowe Price and Fidelity back a new standard of care for cardiovascular disease This press release was updated on July 28, 2022 to reflect that Cleerly...
Qlaris Bio Reports Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile and Positive Efficacy Signal for QLS-101 Findings from First-in-Human Study Support Continued Clinical Development of Investigational IOP-lowering Therapy; New...
Kit Check Recognized as Industry-Leading Vendor for Kit and Tray Management. 65% of participants consider Kit Check to be the top industry leader Washington, D.C. – (June 10, 2022) – Kit Check, the leading automation vendor in Medication Intelligence™, was recently...
Kyruus Announces Paul Merrild as Company’s First President Leadership Team Expansion Follows Year of Accelerated Growth BOSTON, MA – June 29, 2022 – Kyruus, the leader in provider search and scheduling solutions for healthcare organizations, announced that Paul...
Recent Comments